Methotrexate Contamination—China 2007 | IVT


On June 6, 2007, three hospitals in China reported to Chinese Ministry of Health (MOH) and Chinese State Food and Drug Administration (SFDA) that patients undergoing intrathecal methotrexate therapy for leukemia and lymphoma developed severe paraplegia and paresis. Paraplegia is the impairment or complete loss of motor and sensory function in the lower body. Severe cases render patients completely immobile. Paresis is an incomplete paralysis characterized by a partial loss of voluntary movement or by impaired movement. More than 100 cases of severe paraplegia and paresis were reported during the following months.

Download "Methotrexate Contamination—China 2007"

Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.

Comments (0)

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.
Enter the characters shown in the image.
Validated Cloud logo